Company focused on the development and commercialization anti-infective lipid and protein therapeutics

Therapies to defeat infectious diseases and treat Inflammatory conditions for sale. Come with the selling party in contact via Brookz

OMZET

€ 12.000.000

EBITDA

Op aanvraag

AANTAL FTE

11-20

REGIO

Locatie anoniem

SECTOR

Gezondheidszorg & farmacie

TYPE KLANTEN

B2B

PROFIELNUMMER

#29707

RECHTSVORM

Geen rechtsvorm

Beschrijving

 

  • The company is a biopharmaceutical company focused on the development and commercialization of first in class of a new class of novel and groundbreaking anti-infective lipid and protein therapeutics for the treatment and prevention of a variety of infectious diseases and inflammatory conditions.  
  • The company is seeking $4 Million financing at $12 Million pre-money to be used to proceeds for the completion of IND enabling studies & initiation of Phase-1 clinical trials.  
  • The company's lead lipid drug CT-02 has been shown to be effective against SARS- CoV-2, RSV, (H1N1)pdm09 and Rhinoviruses with a single therapeutic agent. 
  • The company’s drug is also a potent anti-inflammatory at the same time. 
  • The company’s drug is naturally present on our lung surface and has been shown to be very safe in multiple animal species. 
  • The company’s drug has the potential for prophylaxis and intervention against a variety of respiratory viruses.  
  • The company’s therapeutic is able to treat multiple viral infections at the same time.  
  • The company’s new therapeutics are very broad-spectrum, safe and effective therapeutics under development.  
  • The company has an exceptional team of leading experts in the fields of Innate Immunology, Bioengineering, Protein & Lipid Chemistry, Pharmacology, Biophysics, infectious diseases that has a proven track record of identifying, patenting, and developing products and technologies for diseases affecting millions of people worldwide.  
  • Raised $610,000 to date.

Offered share
The selling entrepreneur wants to coordinate with the buyer what exactly is being sold.

Reason to sell
Attract capital for further growth.

Transaction
The selling entrepreneur indicates that he is open to both 1) a Share transaction and 2) an Asset transaction. This for discussion in mutual consultation.

Suitable for
This company is interesting for strategic buyers / investors. The company is also interesting for enterprising MBI candidates with knowledge of this sector.

Kantoor uitgelicht

HSA Lawyers

HSA Lawyers is een boutique advocatenkantoor met een focus op M&A, Private Equity, Venture Capital en op ondernemers toegespitst ondernemingsrecht.